Source: Annual Congress 2013 –Murine models of lung immunology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vasiliou, S. Lui, R. Sherburn, S. Saglani, C. M. Lloyd (London, United Kingdom). LSC 2013 abstract - Early sources of IL-13 in house dust mite-induced neonatal allergic airways disease. Eur Respir J 2013; 42: Suppl. 57, 1566

Member's Comments

No comment yet.

Related content which might interest you: Oral presentation: Early sources of IL-13 in house dust mite-induced neonatal allergic airways disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Late Breaking Abstract - Link between IL-22 and IL-10, IL-13, and severity of symptoms in patients with allergic airway diseases caused by house dust mite Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 House dust mite induces direct airway inflammation in vivo: implications for future disease therapy? Source: Eur Respir J 2010; 35: 1377-1387 Year: 2010 Calcaratarin D attenuates house dust mite-induced allergic asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 LSC 2014 abstract - Influenza-induced exacerbation in a murine chronic house dust mite (HDM) asthma model Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models Year: 2014 Late-breaking abstract: House dust mite triggering of Dectin-2 is critical for the initiation of allergic airway inflammation Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease Year: 2011 YS2: Role of Th9 cells in allergic airway inflammation induced by house dust mite Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 Levels of house dust mites (HDM) in homes of patients with bronchial asthma (BA) and the airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 281s Year: 2001 Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 LATE-BREAKING ABSTRACT: IRF3 is required for the induction of allergic airway inflammation by lung dendritic cells in a mouse model of house dust mite-induced atopic asthma Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Young Investigator session: Inhibition of airway hyperresponsiveness and inflammation by vaccination against IL-33 in a house dust mite model of asthma Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 Monitoring spirometry-like parameters in mice with house dust mite-induced experimental asthma Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Sensitisation to house dust mite: its association with bronchial hyperresponsiveness and lung function in asthmatic children Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 OPURIT: Omalizumab-protected ultra rush specific immunotherapy in severe asthmatic patients with house dust mite allergy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Late-breaking abstract: Bronchial allergen challenge with D. Pteronyssinus inhibit blood neutrophil apoptosis in patients with allergic asthma and rhinitis Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease Year: 2011 Implication of NOD-1 receptor in an experimental house dust mite-induced asthma model Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Models to mimic allergic asthma using house dust mite or Aspergillus fumigatus in mice: advantages and disadvantages Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma Year: 2005 High-altitude treatment in atopic and nonatopic patients with severe asthma Source: Eur Respir J 2012; 40: 1374-1380 Year: 2012 Local and systemic inflammatory responses following bronchial instillation of house dust mite allergen (HDM) and HDM/lipopolysaccharide (LPS) in mild asthmatics Source: Annual Congress 2011 - Mechanisms of allergic inflammation of the airways Year: 2011